Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ABSTRACT: Escherichia coli NDM-5 producer

PROVIDER: PRJNA1165667 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other
	SRR30805700_1.fastq.gz	Fastqsanger.gz
	SRR30805700_2.fastq.gz	Fastqsanger.gz
	SRR30805701_1.fastq.gz	Fastqsanger.gz
	SRR30805701_2.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 35

Similar Datasets

Escherichia coli

Project description:NDM Escherichia coli

| PRJNA259763 | ENA

Escherichia coli

Project description:NDM-producing Escherichia coli

| PRJNA270222 | ENA

Project description:NDM-5 Escherichia coli UTI

| PRJNA953650 | ENA

Project description:NDM-5 Escherichia coli UTI

| PRJNA954205 | ENA

Project description:NDM-5 Escherichia coli UTI

| PRJNA953612 | ENA

First dataset - bacterial proteome of carbapanemase-producing Escherichia coli and other Enterobacteriaceae under antibiotic pressure

Project description:Antibiotic resistance associated with the expression of the clinically significant carbapenemases, IMP, KPC, and NDM and OXA-48 in Enterobacteriaceae is emerging as a worldwide calamity to health care. In Australia, IMP-producing Enterobacteriaceae is the most prevalent carbapenemase-producing Enterobacteriaceae (CPE). Genomic characteristics of such carbapenemase-producing Enterobacteriaceae (CPE) are well described, but the corresponding proteome is poorly characterised. We have thus developed a method to analyse dynamic changes in the proteome of CPE under antibiotic pressure. Specifically, we have investigated the effect of meropenem at sub-lethal concentrations to develop a better understanding of how antibiotic pressure leads to resistance. Escherichia coli, producing either NDM, IMP or KPC type carbapenemase were included in this study, and their proteomes were analysed in growth conditions with or without meropenem.

2018-07-11 | PXD008019 | Pride

Study for investigating the effects of a probiotic on diarrhea caused by chemotherapy in patients with gastric, colon and rectum cancer

Project description:Primary objectives: The study investigates whether a Escherichia coli Nissle-suspenison has a (preventive) antidiarrheal effect in patients with tumors who are treated with chemotherapeutic schemes which are associated with increased occurances of diarrhea. Diarrhea caused by treatment are thought to be reduced in intensity and/or frequency by the treatment with Escherichia coli Nissle-Suspension. Primary endpoints: Common toxicity criteria (CTC) for diarrhea

| 2534265 | ecrin-mdr-crc

Escherichia coli NDM-1

Project description:Escherichia coli NDM-1 Genome sequencing

| PRJNA222529 | ENA

Psychological Evaluation According Colonic Colonization by Escherichia Coli of Patients After Colorectal Surgery

Project description:The purpose of this study is to determine whether the presence of pathogenic Escherichia coli in colon is associated with psychiatric disorders.

| 2230352 | ecrin-mdr-crc

Escherichia coli

Project description:Escherichia coli ST349 NDM-1-producing isolates

| PRJNA540019 | ENA